Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Contact tracing performance during the Ebola virus disease outbreak in Kenema district, Sierra Leone.

Senga M, Koi A, Moses L, Wauquier N, Barboza P, Fernandez-Garcia MD, Engedashet E, Kuti-George F, Mitiku AD, Vandi M, Kargbo D, Formenty P, Hugonnet S, Bertherat E, Lane C.

Philos Trans R Soc Lond B Biol Sci. 2017 May 26;372(1721). pii: 20160300. doi: 10.1098/rstb.2016.0300.

PMID:
28396471
2.

After Ebola in West Africa--Unpredictable Risks, Preventable Epidemics.

WHO Ebola Response Team., Agua-Agum J, Allegranzi B, Ariyarajah A, Aylward R, Blake IM, Barboza P, Bausch D, Brennan RJ, Clement P, Coffey P, Cori A, Donnelly CA, Dorigatti I, Drury P, Durski K, Dye C, Eckmanns T, Ferguson NM, Fraser C, Garcia E, Garske T, Gasasira A, Gurry C, Hamblion E, Hinsley W, Holden R, Holmes D, Hugonnet S, Jaramillo Gutierrez G, Jombart T, Kelley E, Santhana R, Mahmoud N, Mills HL, Mohamed Y, Musa E, Naidoo D, Nedjati-Gilani G, Newton E, Norton I, Nouvellet P, Perkins D, Perkins M, Riley S, Schumacher D, Shah A, Tang M, Varsaneux O, Van Kerkhove MD.

N Engl J Med. 2016 Aug 11;375(6):587-96. doi: 10.1056/NEJMsr1513109. No abstract available.

3.

Risk Assessment and Meningococcal A Conjugate Vaccine Introduction in Africa: The District Prioritization Tool.

Cibrelus L, Lingani C, Fernandez K, Djingarey MH, Perea WA, Hugonnet S.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S442-50. doi: 10.1093/cid/civ671.

4.

Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012.

Cibrelus L, Medah I, Koussoubé D, Yélbeogo D, Fernandez K, Lingani C, Djingarey M, Hugonnet S.

Emerg Infect Dis. 2015 Nov;21(11):2063-6. doi: 10.3201/eid2111.150304.

5.

The development of global vaccine stockpiles.

Yen C, Hyde TB, Costa AJ, Fernandez K, Tam JS, Hugonnet S, Huvos AM, Duclos P, Dietz VJ, Burkholder BT.

Lancet Infect Dis. 2015 Mar;15(3):340-7. doi: 10.1016/S1473-3099(14)70999-5. Epub 2015 Feb 6. Review.

6.

West African Ebola epidemic after one year--slowing but not yet under control.

WHO Ebola Response Team., Agua-Agum J, Ariyarajah A, Aylward B, Blake IM, Brennan R, Cori A, Donnelly CA, Dorigatti I, Dye C, Eckmanns T, Ferguson NM, Formenty P, Fraser C, Garcia E, Garske T, Hinsley W, Holmes D, Hugonnet S, Iyengar S, Jombart T, Krishnan R, Meijers S, Mills HL, Mohamed Y, Nedjati-Gilani G, Newton E, Nouvellet P, Pelletier L, Perkins D, Riley S, Sagrado M, Schnitzler J, Schumacher D, Shah A, Van Kerkhove MD, Varsaneux O, Wijekoon Kannangarage N.

N Engl J Med. 2015 Feb 5;372(6):584-7. doi: 10.1056/NEJMc1414992. Epub 2014 Dec 24. No abstract available.

7.

Risk factors for noma disease: a 6-year, prospective, matched case-control study in Niger.

Baratti-Mayer D, Gayet-Ageron A, Hugonnet S, François P, Pittet-Cuenod B, Huyghe A, Bornand JE, Gervaix A, Montandon D, Schrenzel J, Mombelli A, Pittet D; Geneva Study Group on Noma (GESNOMA)..

Lancet Glob Health. 2013 Aug;1(2):e87-96. doi: 10.1016/S2214-109X(13)70015-9. Epub 2013 Jul 5. Erratum in: Lancet Glob Health. 2013 Aug;1(2):e76.

8.

Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination.

Collard JM, Issaka B, Zaneidou M, Hugonnet S, Nicolas P, Taha MK, Greenwood B, Jusot JF.

BMC Infect Dis. 2013 Dec 6;13:576. doi: 10.1186/1471-2334-13-576.

9.

Mobile microbiological laboratory support for evaluation of a meningitis epidemic in Northern Benin.

Njanpop-Lafourcade BM, Hugonnet S, Djogbe H, Kodjo A, N'douba AK, Taha MK, Stoeckel P, Gessner BD.

PLoS One. 2013 Jul 2;8(7):e68401. doi: 10.1371/journal.pone.0068401. Print 2013.

10.

Timely detection of bacterial meningitis epidemics at district level: a study in three countries of the African Meningitis Belt.

Agier L, Broutin H, Bertherat E, Djingarey MH, Lingani C, Perea W, Hugonnet S.

Trans R Soc Trop Med Hyg. 2013 Jan;107(1):30-6. doi: 10.1093/trstmh/trs010.

PMID:
23296695
11.

Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.

Dakar discussion group on priorities for research on epidemic meningococcal disease in Africa., Altmann D, Aseffa A, Bash M, Basta N, Borrow R, Broome C, Caugant D, Clark T, Collard JM, Djingarey M, Goldblatt D, Greenwood B, Griffiths U, Hajjeh R, Hassan-King M, Hugonnet S, Kimball AM, LaForce M, MacLennan C, Maiden MC, Manigart O, Mayer L, Messonnier N, Moisi J, Moore K, Moto DD, Mueller J, Nascimento M, Obaro S, Ouedraogo R, Page AL, Perea W, Pluschke G, Preziosi MP, Sow S, Stephens D, Stuart J, Thomson M, Tiendrebeogo S, Trape JF, Vernet G.

Vaccine. 2013 Mar 1;31(11):1453-7. doi: 10.1016/j.vaccine.2012.12.035. Epub 2012 Dec 27.

12.

Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience.

Djingarey MH, Barry R, Bonkoungou M, Tiendrebeogo S, Sebgo R, Kandolo D, Lingani C, Preziosi MP, Zuber PL, Perea W, Hugonnet S, Dellepiane de Rey Tolve N, Tevi-Benissan C, Clark TA, Mayer LW, Novak R, Messonier NE, Berlier M, Toboe D, Nshimirimana D, Mihigo R, Aguado T, Diomandé F, Kristiansen PA, Caugant DA, Laforce FM.

Vaccine. 2012 May 30;30 Suppl 2:B40-5. doi: 10.1016/j.vaccine.2011.12.073. Review.

PMID:
22607898
13.

Transmission dynamics of methicillin-resistant Staphylococcus aureus in a medical intensive care unit.

Hall IM, Barrass I, Leach S, Pittet D, Hugonnet S.

J R Soc Interface. 2012 Oct 7;9(75):2639-52. doi: 10.1098/rsif.2012.0134. Epub 2012 May 9.

14.

Definition and characterization of localised meningitis epidemics in Burkina Faso: a longitudinal retrospective study.

Tall H, Hugonnet S, Donnen P, Dramaix-Wilmet M, Kambou L, Drabo F, Mueller JE.

BMC Infect Dis. 2012 Jan 5;12:2. doi: 10.1186/1471-2334-12-2.

15.

Patients' beliefs and perceptions of their participation to increase healthcare worker compliance with hand hygiene.

Longtin Y, Sax H, Allegranzi B, Hugonnet S, Pittet D.

Infect Control Hosp Epidemiol. 2009 Sep;30(9):830-9. doi: 10.1086/599118.

PMID:
19642899
16.

Pandemic potential of a strain of influenza A (H1N1): early findings.

Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, Griffin J, Baggaley RF, Jenkins HE, Lyons EJ, Jombart T, Hinsley WR, Grassly NC, Balloux F, Ghani AC, Ferguson NM, Rambaut A, Pybus OG, Lopez-Gatell H, Alpuche-Aranda CM, Chapela IB, Zavala EP, Guevara DM, Checchi F, Garcia E, Hugonnet S, Roth C; WHO Rapid Pandemic Assessment Collaboration..

Science. 2009 Jun 19;324(5934):1557-61. doi: 10.1126/science.1176062. Epub 2009 May 11.

17.

Nosocomial transmission of severe acute respiratory syndrome: better quality of evidence is needed.

Hugonnet S, Legros D, Roth C, Pessoa-Silva CL.

Clin Infect Dis. 2007 Dec 15;45(12):1651; author reply 1652. doi: 10.1086/523725. No abstract available.

PMID:
18190333
18.

Age limit does not replace serologic testing for determination of immune status for measles.

Uckay I, Hugonnet S, Kaiser L, Sax H, Pittet D.

Infect Control Hosp Epidemiol. 2007 Sep;28(9):1117-20. Epub 2007 Jul 3.

PMID:
17932840
19.

Reduction of health care associated infection risk in neonates by successful hand hygiene promotion.

Pessoa-Silva CL, Hugonnet S, Pfister R, Touveneau S, Dharan S, Posfay-Barbe K, Pittet D.

Pediatrics. 2007 Aug;120(2):e382-90. Epub 2007 Jul 30.

PMID:
17664257
20.

Staffing level: a determinant of late-onset ventilator-associated pneumonia.

Hugonnet S, Uçkay I, Pittet D.

Crit Care. 2007;11(4):R80.

Supplemental Content

Loading ...
Support Center